The core activity of Scinora GmbH is the development and provision of animal-free products and services for cell culture, particularly for the production of recombinant proteins and the conduct of in-vitro tests. This includes the development of cell lines, optimization of cell culture media, and provision of solutions for toxicological assessment and exosome production. The company supports the transition from animal-based testing methods to new, animal-free approaches (NAM) and offers customized solutions for cell culture and biopharmaceutical production.